Aberrant DNA Methylation to Predict Metachronous Gastric Neoplasms

Clinical trial NCT04830618 · COMPLETED

Trial details

NCT number: NCT04830618
Sponsor: Seoul National University Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Metachronous Neoplasm Gastric Cancer Gastric Neoplasm Aberrant DNA Methylation

Start date: 2012-09-11
Primary completion: 2017-11-16
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.